Relmada Therapeutics, Inc.
RLMDAs of the close on Sep 25, 2026
Price
$3.83
Market cap
$409M
P/E (diluted TTM)
—
A per-share figure for one of the last four quarters is not shown, so no four-quarter total is given
EPS (TTM)
—
A per-share figure for one of the last four quarters is not shown, so no four-quarter total is given
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Relmada Therapeutics, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 12 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Dec 16, 2025. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Lido Advisors, LLC | 2026-03-31 | 13,905 | Not shown | SEC filing |
| Spruce Street Capital LP | 2026-03-31 | 6,262,114 | Not shown | SEC filing |
| Integral Health Asset Management, LLC | 2026-03-31 | 450,000 | Not shown | SEC filing |
| Corient Private Wealth LLC | 2026-03-31 | 719,582 | Not shown | SEC filing |
| GSA CAPITAL PARTNERS LLP | 2026-03-31 | 19,566 | Not shown | SEC filing |
| Persistent Asset Partners Ltd | 2026-03-31 | 50,773 | Not shown | SEC filing |
| Allworth Financial LP | 2026-03-31 | 2,000 | Not shown | SEC filing |
| RBF Capital, LLC | 2026-03-31 | 120,000 | Not shown | SEC filing |
| MGO ONE SEVEN LLC | 2026-03-31 | 100,000 | Not shown | SEC filing |
| Squarepoint Ops LLC | 2026-03-31 | 63,426 | Not shown | SEC filing |
| UBS Group AG | 2026-03-31 | 126,672 | Not shown | SEC filing |
| American Capital Advisory, LLC | 2026-03-31 | 1,954 | Not shown | SEC filing |
| RA CAPITAL MANAGEMENT, L.P. | 2026-03-31 | 2,947,369 | Not shown | SEC filing |
| BOOTHBAY FUND MANAGEMENT, LLC | 2026-03-31 | 729,055 | Not shown | SEC filing |
| XTX Topco Ltd | 2026-03-31 | 33,606 | Not shown | SEC filing |
| NORTHERN TRUST CORP | 2026-03-31 | 157,734 | Not shown | SEC filing |
| Hudson Bay Capital Management LP | 2026-03-31 | 42,141 | Not shown | SEC filing |
| Sio Capital Management, LLC | 2026-03-31 | 965,000 | Not shown | SEC filing |
| STATE STREET CORP | 2026-03-31 | 357,040 | Not shown | SEC filing |
| Boxer Capital Management, LLC | 2026-03-31 | 842,106 | Not shown | SEC filing |
- Each value is checked against Relmada Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- Pale Fire Capital SE: 44,550 shares reported 2025-12-31; 31,650 shares reported 2026-03-31.
- Point72 Asset Management, L.P.: 187,377 shares reported 2025-12-31; 504,820 shares reported 2026-03-31.
- LMR Partners LLP: 55,600 shares reported 2025-12-31; 63,584 shares reported 2026-03-31.
- BARCLAYS PLC: 60,000 shares reported 2025-12-31; 88,953 shares reported 2026-03-31.
- OSAIC HOLDINGS, INC.: 5 shares reported 2025-12-31; 5 shares reported 2026-03-31.
- SUSQUEHANNA INTERNATIONAL GROUP, LLP: 385,942 shares reported 2025-12-31; 1,011,572 shares reported 2026-03-31.
- OMERS ADMINISTRATION Corp: 65,900 shares reported 2025-12-31; 41,600 shares reported 2026-03-31.
- Qube Research & Technologies Ltd: 155,529 shares reported 2025-12-31; 653,333 shares reported 2026-03-31.
- MORGAN STANLEY: 62,357 shares reported 2025-12-31; 198,463 shares reported 2026-03-31.
- Opaleye Management Inc.: 935,000 shares reported 2025-12-31; 935,000 shares reported 2026-03-31.
- ROYAL BANK OF CANADA: 2,039 shares reported 2025-12-31; 95 shares reported 2026-03-31.
- JANUS HENDERSON GROUP PLC: 7,270,000 shares reported 2025-12-31; 11,063,862 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
82 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Relmada Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-11-05 · Shenouda Maged: Larger than all 35 other insider purchases of Common Stock on file. SEC filing
- 2025-11-05 · TRAVERSA SERGIO: Larger than 34 of the 35 other insider purchases of Common Stock on file. SEC filing
- 2025-05-16 · Ence Chuck: Larger than 33 of the 35 other insider purchases of Common Stock on file. SEC filing
- 2025-05-16 · Kelly Paul Edward: Larger than 32 of the 35 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2025-12-15–2025-12-15: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2025-11-05–2025-11-05: 4 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
- 2025-05-16–2025-05-20: 8 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing )
- 2024-09-09–2024-09-11: 8 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing )
- 2024-01-29–2024-01-31: 9 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-15 | TRAVERSA SERGIO · Chief Executive Officer | Common Stock | P — Open market or private purchase | +27,500 | 4.12 | SEC filing |
| 2025-12-15 | Shenouda Maged · Chief Financial Officer | Common Stock | P — Open market or private purchase | +11,665 | 4.12 | SEC filing |
| 2025-11-05 | Kelly Paul Edward · Chief Operating Officer | Common Stock | P — Open market or private purchase | +90,000 | 2.20 | SEC filing |
| 2025-11-05 | Ence Chuck · CAO and COO | Common Stock | P — Open market or private purchase | +136,000 | 2.20 | SEC filing |
| 2025-11-05 | TRAVERSA SERGIO · Chief Executive Officer | Common Stock | P — Open market or private purchase | +272,500 | 2.20 | SEC filing |
| 2025-11-05 | Shenouda Maged · Chief Financial Officer | Common Stock | P — Open market or private purchase | +500,000 | 2.20 | SEC filing |
| 2025-08-28 | TRAVERSA SERGIO · Chief Executive Officer | Common Stock | P — Open market or private purchase | +55,976 | 0.74 | SEC filing |
| 2025-08-27 | TRAVERSA SERGIO · Chief Executive Officer | Common Stock | P — Open market or private purchase | +129,455 | 0.67 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2025-12-12 | Kelly Paul Edward · COO | Stock Appreciation Rights | A — Grant, award, or other acquisition | +828,000 | SEC filing |
| 2025-12-12 | TRAVERSA SERGIO · Chief Executive Officer | Stock Appreciation Rights | A — Grant, award, or other acquisition | +1,198,000 | SEC filing |
| 2025-12-12 | CASAMENTO CHARLES J · Director | Stock Appreciation Rights | A — Grant, award, or other acquisition | +164,000 | SEC filing |
| 2025-12-12 | Ence Chuck · CA and CO | Stock Appreciation Rights | A — Grant, award, or other acquisition | +828,000 | SEC filing |
| 2025-12-12 | GLASSPOOL JOHN · Director | Stock Appreciation Rights | A — Grant, award, or other acquisition | +164,000 | SEC filing |
| 2025-12-12 | Shenouda Maged · Chief Financial Officer | Stock Appreciation Rights | A — Grant, award, or other acquisition | +828,000 | SEC filing |
| 2025-12-12 | Fedeli Fabiana · Director | Stock Appreciation Rights | A — Grant, award, or other acquisition | +164,000 | SEC filing |
| 2025-06-26 | Ence Chuck · CA and CO | Stock Option (right to buy) | A — Grant, award, or other acquisition | +400,000 | SEC filing |
Showing 8 of 30 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2024-05-24 | Ence Chuck · CA and CO | Stock Option (right to buy) | J — Other acquisition or disposition | −54,624 | SEC filing |
| 2024-05-24 | Shenouda Maged · Chief Financial Officer | Stock Option (right to buy) | J — Other acquisition or disposition | −54,624 | SEC filing |
| 2024-05-24 | GLASSPOOL JOHN · Director | Stock Option (right to buy) | J — Other acquisition or disposition | −20,976 | SEC filing |
| 2024-05-24 | CASAMENTO CHARLES J · Director | Stock Option (right to buy) | J — Other acquisition or disposition | −20,976 | SEC filing |
| 2024-05-24 | Fedeli Fabiana · Director | Stock Option (right to buy) | J — Other acquisition or disposition | −20,976 | SEC filing |
| 2024-05-24 | Kelly Paul Edward · Director | Stock Option (right to buy) | J — Other acquisition or disposition | −43,700 | SEC filing |
| 2024-05-24 | TRAVERSA SERGIO · Chief Executive Officer | Stock Option (right to buy) | J — Other acquisition or disposition | −122,358 | SEC filing |
| 2022-12-16 | Shenouda Maged · CFO | Stock Option (right to buy) | J — Other acquisition or disposition | −200,000 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.